Features associated with surgical outcome in patients with stages 4 and 5 retinopathy of prematurity

Retina

Volumn 23, Issue 3, 2003, Pages 322-329

  Hartnett, M Elizabeth ^a,b,c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Neovascularization; Pediatric ophthalmology; Pediatric retina; Plus disease; Retinal detachment; Retinal features; Stage 4 retinopathy of prematurity; Stage 5 retinopathy of prematurity; Vitreoretinal surgery

Indexed keywords

ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; EXUDATE; FEMALE; FOLLOW UP; HAZE; HUMAN; INFANT; IRIS DISEASE; LENSECTOMY; MALE; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION (PATHOLOGY); OUTCOMES RESEARCH; PLUS DISEASE; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; SCLERA BUCKLING PROCEDURE; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VITRECTOMY; VITREORETINAL DEGENERATION; VITREOUS DISEASE;

EID: 0038418708     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200306000-00006     Document Type: Article

References (33)

1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: Snellen visual acuity and structural outcome at 5 1/2 years after randomization. Arch Ophthalmol 1996;114:417-424.
2. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000;105:295-310.
3. Gibson DL, Sheps SB, Hong Uh S, Schechter MT, McCormick AQ. Retinopathy of prematurity-induced blindness: birthweight specific survival and the new epidemic. Pediatrics 1990;86:405-412.
4. Maguire AM, Trese MT. Visual results of lens-sparing vitreoretinal surgery in infants. J Pediatr Ophthalmol Strabismus 1993;30:28-32.
5. Capone A, Trese MT. Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments. Ophthalmology 2001;108:2068-2070.
6. Hirose T, Katsumi O, Mehta MC, Schepens CL. Vision in stage 5 retinopathy of prematurity after retinal reattachment by open-sky vitrectomy. Arch Ophthalmol 1993;111:345-349.
7. Trese MT, Droste PJ. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity. Ophthalmology 1998;105:992-997.
8. Seaber JH, Machemer R, Eliott D, et al. Long-term visual results of children after initially successful vitrectomy for stage V retinopathy of prematurity. Ophthalmology 1994; 102:199-204.
9. An international classification of retinopathy of prematurity. The committee for the classification of retinopathy of prematurity. Arch Ophthalmol 1984;102(8):1130-1134.
10. Chow DR, Ferrone PJ, Trese MT. Refractive changes associated with scleral buckling and division in retinopathy of prematurity, Arch Ophthalmol 1998;116:1446-1448.
11. Quinn GE, Dobson V, Biglan A, et al. Correlation of retinopathy of prematurity in fellow eyes in the cryotherapy for retinopathy of prematurity study, The Cryotherapy for Retinopathy of Prematurity Cooperative Group, Arch Ophthalmol 1995;113:469-473.
12. Rosner B. Multivariate methods in ophthalmology with application to other paired data situations, Biometrics 1984;25:1025-1035.
13. Pierce E, Foley E, Lois EH, Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity, Arch Ophthalmol 1996;114:1219-1228.
14. Brooks SE, Gu X, Samuel S, et al. Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest Ophthalmol Vis Sci 2001;42:222-228.
15. Klagsbrun M, D'Amore PA, Regulators of angiogenesis. Annu Rev Physiol 1991;53:217-239.
16. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA, Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995;113:1538-1544.
17. Kuroki M, Voest E, Amano S, et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 1996;98:1667-1675.
18. Tolentino MJ, Miller JW, Gragoudas ES, et al, Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 2002;103:1820-1828.
19. Senger DR, Galli SJ, Dvorak AM, et al, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983;219:983-985.
20. Clermont AC, Aiello LP, Mori F, Aiello LM, Bursell S-E. Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol 1997;124:433-446.
21. Dorey CK, Aouididi S, Reynaud X, Dvorak HF, Brown LF. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol 1996;114:1210-1217.
22. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A 1995;92:905-909.
23. Young TL, Anthony DC, Pierce E, Foley E, Smith LEH. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. JAAPOS 1997;1:105-110.
24. Ohno-Matsui K, Hirose A, Yamamoto S, et al. Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment. Am J Path 2002;160:711-719.
25. Lashkari K, Hirose T, Yazdany J, et al. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol 2000;156:1337-1344.
26. Er H, Doganay S, Turkoz Y, et al. The levels of cytokines and nitric oxide in rabbit vitreous humor after retinal laser photocoagulation. Ophthalmic Surg Lasers 2000;31:479-483.
27. Higgins RD, Hendricks Munoz KD, Caines VV, Gerrets RP, Rifkin DB. Hyperoxia stimulates endothelin-1 secretion from endothelial cells: modulation by captopril and nifedipine. Curr Eye Res 1998;17:487-493.
28. Holland D, Saunders R, Kagemann L, et al. Color Doppler imaging of the central retinal artery in premature infants undergoing examination for retinopathy of prematurity. JAAPOS 1999;3:194-198.
29. Greven CM, Tasman W. Rhegmatogenous retinal detachment following cryotherapy in retinopathy of prematurity. Arch Ophthalmol 1989;107:1017-1018.
30. Schwartz SD, Harrison SA, Ferrone PJ, Trese MT. Telemedical evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 2000;107:25-28.
31. Iverson DA, Katsura H, Hartzer MK, Blumenkranz MS. Inhibition of intraocular fibrin formation following infusion of low molecular weight heparin during vitrectomy. Arch Ophthalmol 1991;109:405-409.
32. Connolly BP, Ng EY, McNamara JA, et al. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 2. Refractive outcome. Ophthalmology 2002;109:936-941.
33. Ng EY, Connolly BP, McNamara JA, et al. A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome. Ophthalmology 2002;109:928-934